Skip to content
About Us
Company Profile
Our Management Team
Regulation and Quality
Our values
Our Sites
Isotopia USA
Aseptic plant
Products & Services
Theranostics
Lu177
Diagnostic
Isoprotrace®
Radiopharmacy
PET Products
SPECT Products
Cold Kits
Lu177 Treatment
Services
Partnership
Partnerships & Distribution
Radiopharmaceuticals Companies
News
IsoBlog
Contact us
Careers
About Us
Company Profile
Our Management Team
Regulation and Quality
Our values
Our Sites
Isotopia USA
Aseptic plant
Products & Services
Theranostics
Lu177
Diagnostic
Isoprotrace®
Radiopharmacy
PET Products
SPECT Products
Cold Kits
Lu177 Treatment
Services
Partnership
Partnerships & Distribution
Radiopharmaceuticals Companies
News
IsoBlog
Contact us
Careers
Linkedin
Search
FAPI Articles
Isotopia's Home page
»
FAPI Articles
Scientific Publications
FAPI
Articles
177 Lu-FAPI-46 Therapy in a Patient With End-Stage Metastatic Pancreatic Adenocarcinoma.
Feasibility and Therapeutic Potential of 177 Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers A Preliminary Study.
Physiological tracer distribution and benign lesion incidental uptake of Al 18 F-NOTA-FAPI-04 on PET-CT imaging.
Could Fibroblast Activation Protein (FAP)-Specific Radioligands be considered a pan-tumor agents.
Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology- A Systematic Review.
Theranostic Approach in Breast Cancer A Treasured Tailor for Future Oncology.
Clinical Results of Fibroblast Activation Protein Specific PET and Implications for Radiotherapy Planning- Systematic Review.
Presentations
FAPI Introduction